Anti-ATL effects of a novel synthetic retinoid, am80 (tamibarotene), through inhibition of NF- κB

被引:0
|
作者
Nakazato, Tetsuro
Ishikawa, Chie
Okudaira, Taeko
Tomita, Mariko
Mori, Naoki
机构
[1] Univ Ryukyus, Grad Sch Med, Div Mol Virol & Oncol, Nishihara, Okinawa 90301, Japan
[2] Univ Ryukyus, Fac Med, Div Endocrinol & Metab, Nishihara, Okinawa 90301, Japan
[3] Univ Ryukyus, Fac Med, Div Child Hlth & Welfare, Nishihara, Okinawa 90301, Japan
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:619 / 620
页数:2
相关论文
共 50 条
  • [1] Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis
    T Sanda
    T Kuwano
    S Nakao
    S Iida
    T Ishida
    H Komatsu
    K Shudo
    M Kuwano
    M Ono
    R Ueda
    Leukemia, 2005, 19 : 901 - 909
  • [2] Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis
    Sanda, T
    Kuwano, T
    Nakao, S
    Iida, S
    Ishida, T
    Komatsu, H
    Shudo, K
    Kuwano, M
    Ono, M
    Ueda, R
    LEUKEMIA, 2005, 19 (06) : 901 - 909
  • [3] Anti-adult T-cell leukemia effects of a novel synthetic retinoid, Am80 (Tamibarotene) through inhibition of NF-κB.
    Nakazato, Tetsuro
    Ishikawa, Chie
    Okudaira, Taeko
    Tomita, Mariko
    Mori, Naoki
    BLOOD, 2006, 108 (11) : 714A - 715A
  • [4] Anti-myeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis.
    Sanda, T
    Iida, S
    Kuwano, T
    Ono, M
    Ueda, R
    BLOOD, 2005, 106 (11) : 364B - 364B
  • [5] Anti-adult T-cell leukemia effects of a novel synthetic retinoid, Am80 (Tamibarotene) (Retraction of vol 99, pg 2286, 2008)
    Nakazato, Tetsuro
    Okudaira, Taeko
    Ishikawa, Chie
    Nakama, Shinji
    Sawada, Shigeki
    Tomita, Mariko
    Uchihara, Jun-Nosuke
    Taira, Naoya
    Masuda, Masato
    Tanaka, Yuetsu
    Ohshiro, Kazuiku
    Takasu, Nobuyuki
    Mori, Naoki
    CANCER SCIENCE, 2011, 102 (02): : 499 - 2294
  • [6] A synthetic retinoid Am80 (tamibarotene) rescues the memory deficit caused by scopolamine in a passive avoidance paradigm
    Shudo, K
    Kagechika, H
    Yamazaki, N
    Igarashi, M
    Tateda, C
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (11) : 1887 - 1889
  • [7] Oral Administration of Synthetic Retinoid Am80 (Tamibarotene) Decreases Brain β-Amyloid Peptides in APP23 Mice
    Kawahara, Kohichi
    Nishi, Kentaro
    Suenobu, Michita
    Ohtsuka, Hideyuki
    Maeda, Akira
    Nagatomo, Kenichiro
    Kuniyasu, Akihiko
    Staufenbiel, Matthias
    Nakagomi, Madoka
    Shudo, Koichi
    Nakayama, Hitoshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (07) : 1307 - 1309
  • [8] RETRACTED: Anti-adult T-cell leukemia effects of a novel synthetic retinoid, Am80 (Tamibarotene) (Retracted article. See vol. 102, pg. 499, 2011)
    Nakazato, Tetsuro
    Okudaira, Taeko
    Ishikawa, Chie
    Nakama, Shinji
    Sawada, Shigeki
    Tomita, Mariko
    Uchihara, Jun-nosuke
    Taira, Naoya
    Masuda, Masato
    Tanaka, Yuetsu
    Ohshiro, Kazuiku
    Takasu, Nobuyuki
    Mori, Naoki
    CANCER SCIENCE, 2008, 99 (11): : 2286 - 2294
  • [9] Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer
    Ishigami-Yuasa, Mari
    Ekimoto, Hisao
    Kagechika, Hiroyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (03) : 448 - 452
  • [10] A synthetic retinoid Am80 (tamibarotene) rescues the memory deficit caused by scopolamine in a passive avoidance paradigm (vol 27, pg 1887, 2005)
    Shudo, K
    Kagechika, H
    Yamazaki, N
    Igarashi, M
    Tateda, C
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (12) : 2346 - 2346